Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Conmed (CNMD) Treasury Shares (2016 - 2025)

Historic Treasury Shares for Conmed (CNMD) over the last 16 years, with Q4 2025 value amounting to $12.9 million.

  • Conmed's Treasury Shares fell 1753.38% to $12.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $12.9 million, marking a year-over-year decrease of 1753.38%. This contributed to the annual value of $12.9 million for FY2025, which is 1753.38% down from last year.
  • Conmed's Treasury Shares amounted to $328097.0 in Q4 2025, which was down 1753.46% from $344143.0 recorded in Q3 2025.
  • In the past 5 years, Conmed's Treasury Shares registered a high of $2.2 million during Q1 2021, and its lowest value of $328097.0 during Q4 2025.
  • Its 5-year average for Treasury Shares is $909452.0, with a median of $558850.5 in 2023.
  • Its Treasury Shares has fluctuated over the past 5 years, first tumbled by 6085.65% in 2022, then surged by 1802.09% in 2024.
  • Conmed's Treasury Shares (Quarter) stood at $54.1 million in 2021, then crashed by 57.86% to $22.8 million in 2022, then plummeted by 34.2% to $15.0 million in 2023, then rose by 4.27% to $15.6 million in 2024, then fell by 17.53% to $12.9 million in 2025.
  • Its Treasury Shares was $12.9 million in Q4 2025, compared to $13.5 million in Q3 2025 and $13.9 million in Q2 2025.